INNATE PHARMA
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-09-17
Marcus Jensen
INNATE PHARMA
Equibles does not estimate personal net worth.
About Marcus Jensen
Marcus Jensen has spoken on 1 earnings call across 1 company, most recently for INNATE PHARMA on September 17, 2026. INNATE PHARMA is classified in the Biotechnology industry within the Healthcare sector.
Marcus Jensen on recent calls
“Lekutamab is now progressing towards phase three telemark initiation and then accelerated approval filing. So from a regulatory and development perspective, the path forward is well defined.”
Affiliation history
-
INNATE PHARMA
Transcript header (unverified)
Current
Company network
Recent activity
-
Earnings call
Publication of half year financial statements
INNATE PHARMA